ArticleBMC cancer2023

Exploratory study of an anti-PD-L1/TGF-β antibody, TQB2858, in patients with refractory or recurrent osteosarcoma and alveolar soft part sarcoma: a report from Chinese sarcoma study group (TQB2858-Ib-02).

Lu Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.